๐Ÿฉธ

Hemostasis Process Overview

Jul 12, 2025

Overview

This lecture explains hemostasis, the process of stopping blood loss after vessel injury, including its five key steps and how blood naturally prevents unwanted clotting.

Natural Anticoagulant Mechanisms

  • Endothelial cells secrete nitric oxide and prostacyclin (PGI2) to inhibit platelet activation.
  • Heparan sulfate on endothelial surfaces activates antithrombin III, which inactivates clotting Factors II, IX, and X.
  • Thrombomodulin binds thrombin, which activates protein C; protein C degrades Factors V and VIII to limit coagulation.

Five Steps of Hemostasis

1. Vascular Spasm

  • Injury triggers endothelin release, causing smooth muscle contraction (vasoconstriction) and reduced blood loss.
  • Myogenic response: direct injury prompts smooth muscle contraction.
  • Pain/inflammatory mediators stimulate nociceptors, further enhancing vasoconstriction.

2. Platelet Plug Formation

  • Damaged endothelium releases von Willebrand factor, allowing platelets to bind via glycoprotein 1b receptors.
  • Activated platelets secrete ADP, thromboxane A2, and serotonin, attracting more platelets (aggregation).
  • Platelet-platelet binding uses glycoprotein IIb/IIIa-fibrinogen bridges.
  • Thromboxane A2 and serotonin induce vasoconstriction to support vascular spasm.

3. Coagulation Cascade

  • Intrinsic pathway: Factors XII โ†’ XI โ†’ IX (+ VIII, platelet factor 3, Ca2+) โ†’ X (common pathway).
  • Extrinsic pathway: Tissue factor (III) + Factor VII activates IX & X.
  • Common pathway: Factor X (+ V, platelet factor 3, Ca2+) forms prothrombin activator, converting prothrombin (II) to thrombin.
  • Thrombin converts fibrinogen (I) to insoluble fibrin; Factor XIII cross-links fibrin, forming a stable mesh.

4. Clot Retraction and Repair

  • Platelet actin/myosin contracts, pulling wound edges together.
  • Platelet-derived growth factor stimulates smooth muscle/collagen repair.
  • Vascular endothelial growth factor (VEGF) promotes endothelial regeneration.

5. Fibrinolysis

  • Tissue plasminogen activator (tPA) converts plasminogen to plasmin.
  • Plasmin digests fibrin, dissolving the clot and freeing vessel flow.
  • D-dimers are released as breakdown productsโ€”important for clot diagnostics.

Key Terms & Definitions

  • Hemostasis โ€” Process that stops bleeding at injury sites.
  • Nitric oxide & Prostacyclin (PGI2) โ€” Molecules that inhibit platelet activation.
  • Heparan sulfate โ€” Endothelial surface anticoagulant activating antithrombin III.
  • von Willebrand factor โ€” Protein aiding platelet adhesion to collagen.
  • Glycoprotein 1b/IIb/IIIa โ€” Platelet surface receptors for binding vWF and fibrinogen.
  • Fibrinogen/Fibrin โ€” Plasma proteins forming the clot mesh.
  • Plasminogen/Plasmin โ€” Precursors/proteins responsible for clot breakdown.
  • tPA โ€” Enzyme that activates plasmin for fibrinolysis.
  • D-dimer โ€” Fibrin degradation product used in clot detection tests.

Action Items / Next Steps

  • Review coagulation factor numbers and their order in intrinsic, extrinsic, and common pathways.
  • Memorize key drug targets in hemostasis (e.g., aspirin, clopidogrel, warfarin).
  • Know the five steps of hemostasis and associated key molecules for exams.